Back

Neurocrine Biosciences, Inc.
NBIX
$146.92
-3.23%
Overview
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is engaged in discovering and developing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric...
Open
$0.00
Prior close
$151.83
Today's high
$0.00
Today's low
$0.00
52 Week high
$186.12
52 Week low
$122.14
News
Seeking Alpha • 3 days ago • NBIX
Neurocrine Biosciences, Inc. (NBIX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking Alpha • 8 days ago • NBIX
Neurocrine Biosciences, Inc. (NBIX) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript

Seeking Alpha • 9 days ago • NBIX
Neurocrine Biosciences, Inc. (NBIX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

PRNewsWire • 16 days ago • NBIX
Neurocrine Biosciences to Present at Upcoming Investor Conferences in September

Zacks Investment Research • 18 days ago • NBIX
Neurocrine's Crenessity Gains Ground in CAH: How Far Can Sales Go?
